Search

Philip W. Kantoff, MD, has been named the new Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). An accomplished leader, physician, researcher, and mentor, Dr. Kantoff served the Dana-Farber Cancer Institute and Harvard Medical School (HMS) since 1987 in a variety of capacities. He formally assumes his new position as George J. Bosl, MD, steps down from his role after 18 years.

… Tuesday, November 17, 2015 Philip W. Kantoff, MD, has been named the new Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). An accomplished leader, physician, researcher, and mentor, Dr. Kantoff served the Dana-Farber Cancer Institute and Harvard Medical School (HMS

Memorial Sloan Kettering Cancer Center (MSK) will award three influential cancer researchers with this year’s Paul Marks Prize for Cancer Research. The prize, named in honor of former MSK president Paul Marks, MD, recognizes a new generation of leaders who are making significant contributions to the understanding of cancer or are improving the treatment of the disease.

… Tuesday, November 4, 2025 Memorial Sloan Kettering Cancer Center (MSK) will award three influential cancer researchers with this year’s  Paul Marks Prize for Cancer Research . The prize, named in honor of former MSK president Paul Marks, MD, recognizes a new generation of leaders who are making significant

Memorial Sloan Kettering Cancer Center (MSK) announced its recommitment to communities across Long Island today with the dedication of MSK Nassau, a light-filled 114,000-square-foot outpatient cancer treatment facility centrally located along Hempstead Turnpike. MSK’s newest location, and its third on Long Island, will open for patient care on April 8 with more than 180 dedicated medical and professional staff, all of whom are MSK employees.

… Thursday, April 4, 2019 Memorial Sloan Kettering Cancer Center (MSK) announced its recommitment to communities across Long Island today with the dedication of MSK Nassau, a light-filled 114,000-square-foot outpatient cancer treatment facility centrally located along Hempstead Turnpike. MSK’s newest location

We love our smartphones, but could they be harming our health? An MSK expert weighs in.

… Monday, May 20, 2019 Summary A government-funded study published last year raised concerns about the dangers of cell phone radiation. An MSK radiation expert discusses the study’s limitations and weighs in on the evidence related to cell phone use and cancer risk. Back in 1993, a Florida resident named

Read about a new treatment for leptomeningeal metastasis that is giving patients hope.

… Wednesday, January 28, 2026 VIDEO | 03:35 Watch How Two MSK Labs Came Together to Give a Stage 4 Lung Cancer Patient More Time Every cancer breakthrough begins years before it offers patients new hope. Our series Saved by Science takes you inside MSK’s world class research labs, where you’ll see patients

Deep bonds are forged between MSK’s specialized nurses and their patients during first-in-human trials.

… Friday, December 27, 2019 Summary Deep bonds are forged between MSK’s specialized nurses and their patients during first-in-human trials. It was Monday, July 2, 2018, and the early morning air in Manhattan was humid, thick with anticipation for the upcoming Independence Day holiday. Memorial Sloan Kettering

Androgen deprivation therapy may depress testosterone for prolonged periods in older patients, or those who are on the treatment for more than six months, increasing the risk of associated adverse events, according to the results of our recent retrospective study.

… Tuesday, October 8, 2019 Despite the intention to reduce testosterone temporarily, androgen deprivation therapy (ADT) may lower it for prolonged periods in patients over the age of 65 or those who take ADT for more than six months, according to the results of our recent retrospective study. Given the

An MSK clinical trial is helping Gail Goode overcome multiple myeloma and sheds new light on how cancer affects people of diverse ethnic backgrounds.

… Tuesday, September 3, 2024 There is an urgent need to recruit more diverse patients into cancer clinical trials . One reason it’s so important is that researchers are learning that certain types of cancer occur more frequently in people with certain ancestries. For example:   African — people of African

Un ensayo clínico de MSK está ayudando a Gail Goode a superar el mieloma múltiple y arroja nueva luz sobre cómo el cáncer afecta a personas de diversos orígenes étnicos.

… Tuesday, September 3, 2024 Existe una necesidad urgente de reclutar a pacientes más diversos en los ensayos clínicos de cáncer . Una de las razones por las que es tan importante es que los investigadores están descubriendo que ciertos tipos de cáncer ocurren con mayor frecuencia en personas de determinadas

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.

… Monday, November 25, 2013 Summary Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering. Renowned cancer biologist Joan Massagué has been named